Driving the Best Science to Meet Global Health Challenge s

ITD  
Session 10 
Health, 
sustain ability 
and transdisci-
plinarity 2
08:30 – 10:00 
ITD  
Session 11 
Interdisci-
plinarity in 
universities 
of applied 
sciences‘ 
master studies 
& RDI projects: 
case Finland
08:30 – 10:00 
ITD  
Session 12 
Stakeholder 
engagement in 
sustainability 
assessment – 
transdisciplinary 
challenges in the-
ory and practice – 
collectively testing 
the Sustainability 
Profile Matrix 
along practical 
examples
08:30
08:45
08:45
09:00
09:00 – 09:30 
Plenary 
Session 11 
Disease systems
09:00
09:15
09:15
09:30
09:30 – 10:00 
Plenary 
Session 12 
Health and social
systems
09:30
09:45
09:45
10:00
10:00
10:15
10:15
10:30
10:30 – 12:00 
Parallel  
Session 3.2.17. 
Schistoso-
miasis
10:30 – 12:00 
Parallel 
Session 4.1.2. 
From global 
health 
diplomacy to 
global health 
actions: the 
Northen and 
Southern 
perspectives
10:30 – 12:00 
Parallel 
Session 3.4.3. 
Management 
of protozoal 
and helminthic 
pathogens in 
travellers
10:30 – 12:00 
Parallel 
Session 5.6.5. 
Minimally 
Invasive 
Autopsy (MIA) 
tool for cause 
of death 
investigation 
in developing 
countries
10:30 – 12:00 
Parallel 
Session 4.3.5 . 
Innovative 
communi-
ty-based 
Buruli ulcer 
management 
programs: out-
comes, impact, 
and lessons for 
other disease 
programs
10:30 – 12:00 
Parallel 
Session 4.1.3. 
Health 
insurance 
for rural 
population – 
innovations 
and challenges
10:30 – 12:00 
Parallel 
Session 3.6.1. 
Gut microbiota 
and its 
interaction 
with nutrition 
and diseases
10:30 – 12:00 
Parallel 
Session 3.1.13. 
Malaria control
10:30 – 12:00 
Parallel 
Session 4.3.6. 
Health 
economics
10:30 – 12:00 
Society 
Session 11 
Be-cause 
Health: 
integrated 
mental health 
care: finally 
a different 
perspective 
towards a 
more human 
health care?
10:30 – 12:00 
Parallel 
Session 3.2.12. 
Mycetoma: 
addressing the 
unbearable 
treatment gap
10:30
10:45
10:45 – 12:15 
ITD  
Plenary 4 
ESF-Panel 
Online tools to 
support trans-
disciplinary 
research
10:45
11:00
11:00
11:15
11:15
11:30
11:30
11:45
11:45
12:00
12:00
12:15
12:15
12:30
12:30
12:45
12:45
13:00
13:00 – 14:30 
Plenary 
Session 13 
Closing 
Session
13:00
13:15
13:15
13:30
13:30 – 15:00 
ITD  
Session 13 
Evaluating 
transdici-
plinary collab-
orations
13:30 – 15:00 
ITD  
Session 14 
Inter- and 
transdis-
ciplinary 
approaches 
to include the 
vulnerable, 
build resilience 
and catch 
criminals
13:30 – 15:00 
ITD  
Session 15 
Designing 
transdis-
ciplinary 
research for 
preferred 
outcomes the 
outcome spac-
es framework 
as a starting 
point
13:30 – 15:00 
ITD  
Session 16 
Complexity 
or control? 
Exploring the 
landscape of 
sustainability 
science
13:30
13:45
13:45
14:00
14:00
14:15
14:15
14:30
14:30
14:45
14:45
15:00
15:00
15:15
15:15
15:30
15:30 – 17:15 
ITD  
Plenary 5 
Keynotes 
on new 
developments 
in theory, 
methods, and 
practice of 
transdis-
ciplinary 
research
15:30
15:45
15:45
16:00
16:00
16:15
16:15
16:30
16:30
16:45
16:45
17:00
17:00
17:15
17:15
17:30
17:30
PROGRAMME OVERVIEW 
Thursday, 10 September 2015
p. 107
p. 108
p. 109
p. 109
p. 118
p. 117
p. 117
p. 117
p. 118
p. 119

14
Notes

Scientific Programme ECTMIH

16
SCIENTIFIC PROGRAMME 
Sunday, 6 September 2015
17 .00 – 19 .15
 
Plenary Session 1 
San Francisco 
 
Opening session 
PL1.001 
Musical Welcome: Schola Cantorum Basiliensis, Basel 
17 .00
PL1.002 
Welcome by Congress Co-Chairs
17 .10
 
Christoph Hatz (Basel, CH)  
 
Christian Lengeler (Basel, CH) 
PL1.003 
Greetings from the authorities
17 .20
 
 Guy Morin (Basel, CH)  
Anton Lauber (Basel, CH)  
Mauro Dell’Ambrogio (Berne, CH)  
Pascal Strupler (Berne, CH)  
Manuel Sager (Berne, CH)  
Line Matthiessen (Brussels, BE)  
Nkandu Luo (Lusaka, ZM)  
Gerri McHugh (London, GB) 
PL1.004 
Musical Entr‘acte: Schola Cantorum Basiliensis, 
18 .00
 Basel
PL1.005 
Introduction to inaugural plenaries by Chairman of the
18 .15
 
Scientific Committee
Marcel Tanner (Basel, CH) 
PL1.006 
Challenges of global health in post-MDG area: the public
18 .20
 
and global health perspectives
Matshidiso Moeti (Brazzaville, CG) 
PL1.007 
Challenges of global health in the post-MDG area:  
18 .40
 
a science perspective
Peter Piot (London, GB) 
PL1.008 
Musical Closure: „Stickstoff“ 
19 .00
 
19 .15
 
Networking Get Together 
 Foyer
 
Please refer to the ECTMIH mobile app  
(San Francisco) 
 
for details
20 .45
 
Film Presentation 
  San Francisco
 
Ce n’est pas une vie que de ne pas bouger
Please refer to the ECTMIH mobile app  
for details

17
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
09 .00 – 09 .30
 
Plenary Session 2 
San Francisco 
 
Disease systems 
 
Chair: Manuel Battegay (Basel, CH) 
INV.PL2.001  
Medical HIV prevention: science, public health and medical 
ethics
J .D . Lundgren (Copenhagen, DK) 
09 .30 – 10 .00
 
Plenary Session 3 
San Francisco 
 
Health and social systems 
 
Chair: Sharon Fonn (Johannesburg, ZA) 
INV.PL3.001 
Managing decentralisation and community participation
Margaret Gyapong (Accra, GH) 
10 .30 – 12 .00
 
Parallel Session 5.1.1. 
San Francisco
 
(From research to implementation) 
 
Molecular approaches for health 
 
Convener and Chair: Hans-Peter Beck (Basel, CH) 
INV.5.1.1.001 
Proteomics to investigate developmental differentiation 
10 .30
 
in Trypanosomes
Falk Butter (Mainz, DE) 
O.5.1.1.002 
A multi-protein complex between the GPI-anchored CyRPA
11 .00
 
with PfRH5 and PfRipr is crucial for 
 
Plasmodium falciparum erythrocyte invasion
 E . Amlabu, K .S . Reddy, A .K . Pandey, P . Mitra, V .S . Chauhan, 
D . Gaur (New Delhi, IN; Anyigba, NG) 
O.5.1.1.003 
Assessing the var gene expression of CIDRα1-subtypes
11 .15
 
associated with EPCR-binding in Plasmodium falciparum 
parasites isolated from hospitalized Tanzanian children 
with severe malaria
S .I . Mkumbaye (Moshi, Tanga, TZ; Copenhagen, DK) 
O.5.1.1.004 
A hybridization-based enrichment strategy to increase the 
11 .30
 
accuracy of next generation sequencing in phylogenetic 
analysis of dengue viruses in Sri Lanka
 A . Uehara, U .S . Kamaraj, H .A . Tissera, A . Amarasinghe, 
P . Palihawadana, S . Gunasena, X .M . Ong, S . Howe, 
A .D . Desilva, A . Wilder-Smith, D .J . Gubler, O .M . Sessions 
(Singapore, SG; Colombo, LK; Umea, SE; Durham, US) 
O.5.1.1.005 
Protein transport mechanisms in Plasmodium falciparum
11 .45
 
as novel anti-malarial drug targets
 K . Rawat, K .M . Kibria, M . Panchal, J .B . Dacks, A . Mohmmed, 
R . Tuteja, P . Malhotra (New Delhi, IN; Edmonton, CA) 

18
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
10 .30 – 12 .00
 
Parallel Session 5.3.1. 
Sydney
 
(From research to implementation) 
 
 Challenges of research targeting children’s health in 
resource poor settings and the uptake of results 
 
Convener and Chair: Line Matthiessen (Brussels, BE)  
 
Chair: Charles Mgone (The Hague, NL) 
INV.5.3.1.001 
Introduction by the co-chairs
10 .30
 
Line Matthiessen (Brussels, BE) 
 
Charles Mgone (The Hague, NL) 
INV.5.3.1.002 
Evidence, knowledge to action: children health 
10 .40
 interventions
Nkandu Luo (Lusaka, ZM) 
INV.5.3.1.003 
Global research in paediatrics
11 .00
 
Carlo Giaquinto (Padova, IT) 
INV.5.3.1.004 
Optimising the impact and cost-effectiveness of child 
11 .07
 
health intervention programmes of vaccines and micro-
nutrients in low-income countries
Amabelia Rodrigues (Bissau, GW) 
INV.5.3.1.005 
Children with HIV in Africa – pharmacokinetics and 
11 .14
 
adherence/acceptability of simple antiretroviral regimens
Veronica Mulenga (Lusaka, ZM) 
INV.5.3.1.006 
Challenges of research targeting children’s health in 
11 .21
 
resource poor settings and the uptake of results – Industry 
Perspective
Jutta Reinhard-Rupp (Coinsins, CH) 
 
Discussion by panelists & questions from the audience 
 
Symposium closure 

19
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Parallel Session 4.1.1. 
Singapore
 
(Health and social systems) 
 
 When people have a say… Participatory health 
governance, social accountability & access to local 
resources 
 
Convener and Chair: Jacques Mader (Berne, CH) 
INV.4.1.1.001 
Welcome and facilitation
10 .30 
Jacques Mader (Berne, CH) 
INV.4.1.1.002 
When people have a say… Participatory health governance,
10 .35
 
social accountability & access to local resources
Louise Potvin (Montreal, CA) 
INV.4.1.1.003 
Public accountability practices of district health 
10 .55
 
management teams: a realist inquiry in two local health 
systems in Ghana
S . Van Belle (Antwerp, BE) 
INV.4.1.1.004 
Information is power: experimental evidence of the longer 
11 .10
 
run impact of a local accountability intervention in 
primary health care provision in Uganda
Jakob Svensson (Stockholm, SE) 
INV.4.1.1.005 
Engaging marginalized communities in participatory 
11 .25
 
decision-making and accountability in health: challenges 
and lessons learned
Walter Flores (GT) 
11 .40
 
Q & A 
INV.4.1.1.006 
Wrap up and take home messages
11 .55
 
Flora Kessy (Ifakara, TZ) 
10 .30 – 12 .00
 
Parallel Session 3.1.10. 
Montreal
 
(Disease systems) 
 
Antimalarials: advances in field monitoring  
programmes 
 
Convener and Chair: Núria Casamitjana (Barcelona, ES) 
INV.3.1.10.001 
Introduction and context
10 .30
 
Wilfred F . Mbacham (Yaoundé, CM) 
INV.3.1.10.002 
Monitoring efficacy of antimalarials over time and 
10 .50
 
geographic areas
Jean Louis Abdourahim Ndiaye (Dakar Fann, SN) 
INV.3.1.10.003 
Monitoring safety of antimalarials over time and 
11 .10
 
geographic areas
Christophe Rogier (Antananarivo, MG) 
INV.3.1.10.004 
Socio anthropological considerations in community health
11 .30
 
workers’ role and patients’ perceptions of medicines
Jean Yves Le Hesran (Paris Cedex 6, FR) 

20
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
10 .30 – 12 .00
 
Parallel Session 3.1.4. 
Delhi
 
(Disease systems) 
 
P. vivax – and its importance 
 
Convener and Chair: Ivo Mueller (Barcelona, ES) 
INV.3.1.4.001 
Development of vaccines for P. vivax malaria
10 .30
 
Chetan Chitnis (Paris, FR) 
O.3.1.4.002 
Malaria elimination in the Asia-Pacific: addressing the 
11 .00
 
P. vivax challenge
I . Mueller (Barcelona, ES; Melbourne, AU) 
O.3.1.4.003 
Killing the hypnozoite: drug discovery approaches to
11 .15
 
prevent relapse in Plasmodium vivax
B . Campo, O . Vandal, D . Wesche, T .N . Wells, J .N . Burrows 
(Geneva, CH; Princeton, Seattle, US) 
O.3.1.4.004 
Development of an Anopheles vector and tools to study
11 .30
 
Plasmodium cynomolgi, a surrogate for P. vivax
L . Lim, R .S . Made Ali, J .T . Yip, J . Qian, B .H . Tan, A . Chua, 
B .K . Yeung, P .Y . Shi, T .T . Diagana, R . Ubalee, J .P . Bifani 
(Singapore, SG; Bangkok, TH) 
O.3.1.4.005 
Confirmed Plasmodium vivax resistance to chloroquine in
11 .45
 
Central Vietnam
P .V . Thanh, N .V . Hong, N .V . Van, M . Louisa, K . Baird, 
T .T . Tinh, N .X . Xa, K . Peeters Grietens, L .X . Hung, T .T . Duong, 
A . Rosanas-Urgell, N . Speybroeck, U . D‘Alessandro, A . Erhart 
(Hanoi, Tam Ky, VN; Antwerp, Brussels, BE; Jakarta, ID; 
London, GB; Fajara, GM) 

21
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Late Breaker Abstract Session 1 
Boston 1 
 
Chair: Martin Röösli (Basel, CH) 
O.LB1.001 
Pyrethroid and DDT resistance in Anopheles gambiae from
10 .30
 
Taabo, south-central Cote d’Ivoire
G .L . Bellai, C .S . Mouhamadou, A .M . Adja, K .E . N‘goran 
(Abidjan, CI) 
O.LB1.002 
Stool-based polymerase chain reaction for the diagnosis of
10 .45
 
multiple pathogens in Mali: a case-control study
J . Jasuja, J . Veit, H .K .M . Fofana, A . Nimmesgern, R . Saye, 
M .N . Doumbia, A . Landouré, M .S . Traoré, M . Herrmann, P . Yap, 
K . Polman, M . Boelaert, F . Chappuis, J . Utzinger, M . Sacko, 
L . von Müller, S .L . Becker (Homburg/Saar, DE; Bamako, ML; 
Basel, Geneva, CH; Antwerp, BE) 
O.LB1.003 
Why such a high prevalence of epilepsy in the Orientale
11 .00
 
Province in the Democratic Republic of the Congo (DRC)?
R . Colebunders, F . Tepage, M . Mandro, G . Musinya, 
G . Mambandu, J .L . Mokili, K . Pfarr, E . Rood, A . Laudisoit 
(Antwerp, BE; Bunia, Bunja, Kisangani, CD; San Diego, US; 
Bonn, DE; Amsterdam, NL; Liverpool, GB) 
O.LB1.004 
Evaluation of sulphadoxine-pyrimethamine for intermittent
11 .15
 
preventive treatment of malaria in pregnancy: a 
retrospective birth outcomes study in Mansa, Zambia
V . Chalwe (Lusaka, ZM) 
O.LB1.005 
Strengthening Publications Reporting Infections in 
11 .30
 
Newborns Globally (SPRING) international survey on the 
criteria for reporting neonatal infections
S . Vergnano, E . Anderson, A . Seale, P .T . Heath, S . Saha, 
M . Sharland, J . Lawn (London, GB; Dhaka, BD) 
O.LB1.006 
Effectiveness and sustainability of a six month peer 
11 .45
 
support based physical activity intervention trial among 
sedentary women in Thiruvananthapuram City, India
E . Mathews, M . Pratt, K .R . Thankappan (Trivandrum, IN; 
Atlanta, US) 
 

22
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
10 .30 – 12 .00
 
Parallel Session 3.4.2. 
Boston 2
 
(Disease systems) 
 
Resistant bacteria and viruses in a mobile world 
 
Convener and Chair: Jean Pieters (Basel, CH) 
INV.3.4.2.001 
Opportunities and challenges for vaccines
10 .30
 
Rino Rappuoli (Siena, IT) 
O.3.4.2.002 
Detection of hospital acquired infections and antibiotic 
11 .00
 
selection in neonatal ICU in El-Husain University Hospital 
M .M . El-Bahnasawy, M .K . El-Tohamy, M .F . Mohamed, R .Z . Abd 
El-Rahman (Cairo, EG) 
O.3.4.2.003 
Possible nosocomial transmission as a cause of secondary
11 .15
 
infection and healing delay of Buruli ulcer wounds
G .S . Kpeli, E . Owusu-Mireku, A . Lamelas, I .D . Otchere, 
S .Y . Aboagye, E . Ampadu, G . Pluschke, D . Yeboah-Manu 
(Accra, GH; Basel, CH) 
O.3.4.2.004 
Device-associated infections at El-Salam Hospital in Cairo
11 .30
 
M .M . El-Bahnasawy (Cairo, EG) 
O.3.4.2.005 
Analysis of prescription behaviour and structural barriers
11 .45
 
for rational use of antibiotics at a tertiary hospital in 
Malawi 
N .A . Mensah Abrampah, K . Groeschner, H .F . Neuhann, 
T . Hamisi (Berlin, Heidelberg, DE; Lilongwe, MW) 
 
10 .30 – 12 .00
 
Society Session 1 
Shanghai 1 
 
 Société de Pathologie Exotique (SPE), Italian Society 
of Tropical Medicine and Global Health (SIMET) and 
Sociedad Española de Medicina Tropical y Salud 
Internacional (SEMTSI): Rapid diagnosis tests (RDTs) 
in tropical infectiology 1 
 
Chair: Yves Buisson (Paris, FR) 
 
Chair: Francesco Castelli (Brescia, IT) 
SS1.001 
Rapid diagnostic tests for leishmaniasis: an overview
10 .30
 
Israel Cruz (Geneva, CH) 
SS1.002 
HIV testing in developing countries: from laboratory to
10 .50
 
home testing
François Simon (Paris, FR)  
Jean Christophe Plantier (Rouen, FR) 
O.SS1.003 
Performance comparison of three rapid diagnostic tests
11 .10
 
for the serodiagnosis of hepatic cystic echinococcosis in 
humans
F . Tamarozzi, I . Covini, M . Mariconti, R . Narra, C . Tinelli, A . De 
Silvestri, F . Manzoni, A . Casulli, E . Brunetti (Pavia, Roma, IT) 
SS1.004 
Development and field assessment of the rapid diagnostic
11 .30
 
test Ebola eZyscreen
®
Laurent Bellanger (Marcoule, FR)  
Fabrice Gallais (Marcoule, FR) 
11 .50
 Discussion 

23
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Parallel Session 3.2.18.  
Shanghai 2
 
(Disease systems) 
 
Buruli and other NTDs 
 
Convener and Chair: Gerd Pluschke (Basel, CH) 
O.3.2.18.001 
The role of molecular diagnostics in the clinical 
10 .30
 
management and control of Buruli ulcer disease and  
leprosy – two neglected mycobacterial diseases
M . Beissner, R .O . Phillips, K . Badziklou, M . Bauer, 
A . Wöstemeier, F .S . Sarfo, I . Maman, D . Symank, M . Jansson, 
A . Rhomberg, F .X . Wiedemann, A . Banla Kere, T . Löscher, 
G . Bretzel (Munich, DE; Kumasi, GH; Lomé, TG) 
O.3.2.18.002 
On the way to point-of-care diagnostics for Buruli ulcer: 
10 .45
 
an antigen capture approach
K . Röltgen, A . Dreyer, J .-P . Dangy, N . Scherr, M .-T . Ruf, 
S . Kerber, J . Ndung`u, G . Pluschke (Basel, Geneva, CH) 
O.3.2.18.003 
Performance of a clinical score for the diagnosis of Myco-
11 .00